Abstract: A fuel rail assembly for delivering fuel to at least one fuel injector. The assembly includes a main pipe defining a passageway through which fuel passes to the fuel injector. A fastener mount is forged with the main pipe such that the fastener mount is integral with the main pipe. The fastener mount defines a first aperture configured to receive a fastener for mounting the main pipe. A wire harness mount is forged with the main pipe such that the wire harness mount is integral with the main pipe. The wire harness mount defines a second aperture configured to cooperate with a coupling member of a wire harness. The fastener mount and the wire harness mount are on a common side of the main pipe.

Abstract: A fuel delivery system for an engine includes a fuel rail, a fuel injector, and a clip. The fuel rail has a cup that defines an opening. The fuel injector has an upper end that is disposed within the opening such that the cup and fuel injector are axially aligned. The clip is secured to the fuel injector and engages the cup to orient the fuel injector radially relative to the cup. The clip has a tab that extends outward relative to the fuel injector. The tab defines a central orifice that is configured to receive a fastener. The fastener is configured to mount a wire harness.

Abstract: A fuel delivery system for an engine includes a fuel rail, a fuel injector, and a clip. The fuel rail has a cup that defines an opening. The fuel injector has an upper end that is disposed within the opening such that the cup and fuel injector are axially aligned. The clip is secured to the fuel injector and engages the cup to orient the fuel injector radially relative to the cup. The clip has a tab that extends outward relative to the fuel injector. The tab defines a central orifice that is configured to receive a fastener. The fastener is configured to mount a wire harness.

Abstract: A fuel delivery system for an engine includes a fuel rail cup, a fuel injector, and a retainer clip. The fuel rail cup extends along a longitudinal axis and defines an opening that extends radially outward from the longitudinal axis. The fuel injector has an upper end that is disposed within the opening such that the cup and fuel injector are aligned along the longitudinal axis. The retainer clip has a central body and at least one prong that protrudes upward from the central body. The central body engages the fuel injector and the at least one prong engages the fuel rail cup such that the clip inhibits axial movement of the fuel injector relative to the fuel rail cup along the longitudinal axis and such that the clip inhibits rotation of the fuel injector relative to the fuel rail cup about the longitudinal axis.

Abstract: The Opposing Fields Generator is an energy producing device using opposing magnetic fields to produce energy through the implementation of any combination of strategic gearing, displacement, and shielding technologies to allow movement. This invention overcomes the problem of fixed magnetic fields interfering with one another at the point where a moving armature or other motion device cannot continue its movement by displacing one or more of the magnets' magnetic fields in order to redirect the magnetic energy to allow the rotor or other moving part to pass by and continue to make repeated rotations (or other movements) without the need to use any exterior energy sources.

Abstract: The MagnaForce Generator is an energy producing device using magnetic force in a way that allows continuous movement to produce energy. The device described above where one or more of the magnets are attached to a device which moves the magnet(s) to maximize the free flow of the movement created by the magnetic fields. Most likely magnets in a circle with a spinning magnet on a shaft in the middle The device described incorporates piston(s) which retreats into a cylinder to avoid opposing forces from or related to the primary rotational device that do not complement the production of energy and that emerge to assist in the production. The device incorporates materials that redirect the magnetic fields to maximize the production of energy. The device described might incorporate any pre-existing braking device. The device described might incorporate a pre-existing generating device. The device described might incorporate a locomotive device.

Abstract: Non-C2-symmetric bisphospholane ligands and methods for their preparation are described. Use of metal/non-C2-symmetric bisphospholane complexes to catalyze asymmetric transformation reactions to provide high enantiomeric excesses of formed compounds is also described.

Abstract: Materials and methods for preparing P-chirogenic monophospholanes and bisphospholanes are disclosed. The methods employ stereoselective cyclization to generate the phospholane rings followed by pyramidal inversion to access a variety of P-chirogenic phospholanes. When bound to transition metals such as rhodium, the disclosed P-chirogenic phospholanes may be used as catalysts in asymmetric synthesis of valuable pharmaceutical chemical entities, including pregabalin.

Abstract: The Pharmaceutical Safety Terminal, PST, uses a computer download of the physician's desk reference, PDR, or similar data as one source of reference input. The other primary source of data input is the patient's medical profile. The PST automatically calculates the perceived safety of each medication with the risk factor in the patient's profile. On the side of this approximately 3 inch by 3½ inch device is a green, red, and yellow light. If the red light shows the doctor must realize that the medication is strongly counter indicated. Yellow means use caution and green means there are no exceptional warning signs. The PST slides on the physician's belt so he will carry it at all times. The PST also gives a graphic read out of the possible side effects of each drug typed into the patient's profile. So the doctor can read the specifics of each drug interaction before it is administered to the patient.

Abstract: P-chiral bisphospholane ligands and methods for their preparation are described. Use of metal/P-chiral bisphospholane complexes to catalyze asymmetric transformation reactions to provide high enantiomeric excesses of formed compounds is also described.

Abstract: Non-C2-symmetric bisphospholane ligands and methods for their preparation are described. Use of metal/non-C2-symmetric bisphospholane complexes to catalyze asymmetric transformation reactions to provide high enantiomeric excesses of formed compounds is also described.

Abstract: P-chiral bisphospholane ligands and methods for their preparation are described. Use of metal/P-chiral bisphospholane complexes to catalyze asymmetric transformation reactions to provide high enantiomeric excesses of formed compounds is also described.

Abstract: Non-C2-symmetric bisphospholane ligands and methods for their preparation are described. Use of metal/non-C2-symmetric bisphospholane complexes to catalyze asymmetric transformation reactions to provide high enantiomeric excesses of formed compounds is also described.

Abstract: P-chiral bisphospholane ligands and methods for their preparation are described. Use of metal/P-chiral bisphospholane complexes to catalyze asymmetric transformation reactions to provide high enantiomeric excesses of formed compounds is also described.

Abstract: Non-C2-symmetric bisphospholane ligands and methods for their preparation are described. Use of metal/non-C2-symmetric bisphospholane complexes to catalyze asymmetric transformation reactions to provide high enantiomeric excesses of formed compounds is also described.

Abstract: P-chiral bisphospholane ligands and methods for their preparation are described. Use of metal/P-chiral bisphospholane complexes to catalyze asymmetric transformation reactions to provide high enantiomeric excesses of formed compounds is also described.

Abstract: P-chiral bisphospholane ligands and methods for their preparation are described. Use of metal/P-chiral bisphospholane complexes to catalyze asymmetric transformation reactions to provide high enantiomeric excesses of formed compounds is also described.

Abstract: Non-C2-symmetric bisphospholane ligands and methods for their preparation are described. Use of metal/non-C2-symmetric bisphospholane complexes to catalyze asymmetric transformation reactions to provide high enantiomeric excesses of formed compounds is also described.

Abstract: Non-C2-symmetric bisphospholane ligands and methods for their preparation are described. Use of metal/non-C2-symmetric bisphospholane complexes to catalyze asymmetric transformation reactions to provide high enantiomeric excesses of formed compounds is also described.

Abstract: P-chiral bisphospholane ligands and methods for their preparation are described. Use of metal/P-chiral bisphospholane complexes to catalyze asymmetric transformation reactions to provide high enantiomeric excesses of formed compounds is also described.